Last 4,825 GBp
Change Today -8.00 / -0.17%
Volume 249.6K
SHP On Other Exchanges
Symbol
Exchange
SHP is not on other exchanges.
As of 5:22 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip J. Vickers Ph.D.

Head of Research and Development, Shire plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

----

Background*

Dr. Philip J. Vickers, also known as Phil, Ph.D., serves as Head of Research and Development at Shire plc. Dr. Vickers serves as the Head of Research & Development at Shire Human Genetic Therapies Inc. Dr. Vickers served as Senior Vice President of Research & Development of Shire Human Genetic Therapies Inc. Dr. Vickers is responsible for leading global R&D for Shire HGT and for establishing the strategic direction of Shire's pipeline. He is a Senior Executive with more ...

Read Full Background

Corporate Headquarters*

5 Riverwalk
Dublin, Co. Dublin 24

Ireland

Phone: 353 1 429 7700
Fax: --

Board Members Memberships*

2009-N/A
Former Chief Scientific Officer and Director

Education*

PhD
University of Toronto
BS
Salford University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 4,825.00 GBp -8.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
$3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.